• SENSEX
    NIFTY 50
Market

Glenmark Pharma shares surge 10% on development of anti-retroviral for COVID-19 treatment

Updated : April 23, 2020 01:26 PM IST

Clinical trials for the drug will last around 14 days to 1 month.
Once the company passes through clinical trials, it can launch the drug in the Indian market.
Glenmark Pharma shares surge 10% on development of anti-retroviral for COVID-19 treatment

You May Also Like

Live TV
Advertisement